RNXT
Price:
$0.95
Market Cap:
$34.82M
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.
Industry
Biotechnology
IPO Date
2021-08-26
Stock Exchange
NASDAQ
Ticker
RNXT
According to RenovoRx, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 22.76M. This represents a change of -0.75% compared to the average of 22.93M of the last 4 quarters.
The mean historical Enterprise Value of RenovoRx, Inc. over the last ten years is 73.29M. The current 22.76M Enterprise Value has changed 3.01% with respect to the historical average. Over the past ten years (40 quarters), RNXT's Enterprise Value was at its highest in in the December 2020 quarter at 124.75M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
73.29M
Median
58.62M
Minimum
23.58M
Maximum
136.06M
Discovering the peaks and valleys of RenovoRx, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 27.30%
Maximum Annual Enterprise Value = 136.06M
Minimum Annual Increase = -49.36%
Minimum Annual Enterprise Value = 23.58M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 23.58M | -48.70% |
| 2023 | 45.96M | 27.30% |
| 2022 | 36.10M | -49.36% |
| 2021 | 71.29M | -43.76% |
| 2020 | 126.77M | -6.83% |
The current Enterprise Value of RenovoRx, Inc. (RNXT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
35.21M
5-year avg
60.74M
10-year avg
73.29M
RenovoRx, Inc.’s Enterprise Value is less than Elutia Inc. (54.96M), less than Lantern Pharma Inc. (36.25M), less than Reviva Pharmaceuticals Holdings, Inc. (30.06M), less than MAIA Biotechnology, Inc. (34.29M), greater than Annovis Bio, Inc. (-17038803690.00), greater than Tvardi Therapeutics, Inc. (18.02M), less than Celularity Inc. (112.66M), less than CalciMedica, Inc. (60.38M), less than BioAtla, Inc. (47.72M), less than PolyPid Ltd. (31.37M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 54.96M | $29.45M | |
| 36.25M | $42.17M | |
| 30.06M | $40.31M | |
| 34.29M | $44.44M | |
| -17038803690.00 | $91.48M | |
| 18.02M | $39.21M | |
| 112.66M | $47.46M | |
| 60.38M | $65.85M | |
| 47.72M | $49.86M | |
| 31.37M | $40.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RenovoRx, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like RenovoRx, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is RenovoRx, Inc.'s Enterprise Value?
What is the highest Enterprise Value for RenovoRx, Inc. (RNXT)?
What is the 3-year average Enterprise Value for RenovoRx, Inc. (RNXT)?
What is the 5-year average Enterprise Value for RenovoRx, Inc. (RNXT)?
How does the current Enterprise Value for RenovoRx, Inc. (RNXT) compare to its historical average?